Loading company…
Tensha Therapeutics developed cancer therapies focused on BET inhibitors.
Tensha Therapeutics focused on developing BET inhibitors for cancer treatment. Based in Cambridge, US, the company was acquired by Roche in January 2016 for USD 115 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in